Skip to main content
Top
Published in: Journal of Cancer Education 1/2015

01-03-2015

Impact of Primary Care Provider Knowledge, Attitudes, and Beliefs about Cancer Clinical Trials: Implications for Referral, Education and Advocacy

Authors: Margo Michaels, Thomas A. D’Agostino, Natasha Blakeney, Elisa S. Weiss, Maria C. Binz-Scharf, Mitch Golant, Carma L. Bylund

Published in: Journal of Cancer Education | Issue 1/2015

Login to get access

Abstract

Primary Care Providers (PCPs) can be instrumental in helping to prepare patients for referral to cancer treatment. It has been suggested that PCPs can have an important impact on priming patients about the possibility of receiving care within a cancer treatment clinical trial (CCT). However, little is understood about how to effectively engage primary care providers in educating patients about trials. Data were collected as part of two qualitative research projects about primary care providers’ role in referral to treatment and to CCTs. Participants were 27 PCPs who agreed to take part in qualitative face-to-face or telephone interviews and serve predominantly underserved, minority populations. Interviews identified a number of factors influencing referral to oncologists, including patients’ insurance coverage, location and proximity to treatment facilities, and the strength of ongoing relationships with and/or previous experience with a specialist. PCPs overwhelmingly expressed disinterest in discussing any treatment options, including CCTs. Misconceptions about quality of care received through trials were also common, presenting a deterrent to discussion. PCPs need targeted, evidence-based educational interventions to appropriately address their concerns about cancer clinical trials, enhance provider communication skills, and alter patient referral behavior. Steps must also be taken to strengthen communication between oncologists and referring PCPs.
Literature
1.
go back to reference American College of Surgeons: Commission on Cancer. 2009. Cancer Program Standards, revised edition. Chicago, IL American College of Surgeons: Commission on Cancer. 2009. Cancer Program Standards, revised edition. Chicago, IL
2.
go back to reference Nass JS, Moses HL, Mendelsohn J (2010) A National Cancer Clinical Trials System for the 21st century: reinvigorating the NCI Cooperative Group Program. The National Academies Press, Washington Nass JS, Moses HL, Mendelsohn J (2010) A National Cancer Clinical Trials System for the 21st century: reinvigorating the NCI Cooperative Group Program. The National Academies Press, Washington
3.
go back to reference Murthy VH, Krumholz HM, Gross CP (2004) Participation in cancer clinical trials: race-, sex-, and age-based disparities. J Am Med Assoc 291:2720–2726CrossRef Murthy VH, Krumholz HM, Gross CP (2004) Participation in cancer clinical trials: race-, sex-, and age-based disparities. J Am Med Assoc 291:2720–2726CrossRef
4.
go back to reference Powe, Neil R., Tiffany L. Gary. 2004. Clinical trials chapter in Race and research in focus:perspectives on minority participation in health studies. Bettina M, editor. American Public Health Association Powe, Neil R., Tiffany L. Gary. 2004. Clinical trials chapter in Race and research in focus:perspectives on minority participation in health studies. Bettina M, editor. American Public Health Association
5.
go back to reference Stewart JH, Bertoni AG, Staten JL et al (2007) Participation in surgical oncology clinical trials: gender-, race/ethnicity-, and age-based disparities. Ann Surg Oncol 14:3328–3334CrossRefPubMed Stewart JH, Bertoni AG, Staten JL et al (2007) Participation in surgical oncology clinical trials: gender-, race/ethnicity-, and age-based disparities. Ann Surg Oncol 14:3328–3334CrossRefPubMed
9.
go back to reference Ford JG, Howerton MW, Bolen S et al (2005) Knowledge and access to information on recruitment of underrepresented populations to cancer clinical trials. Evidence Report Technology Assessment (Summary) 122:1–11. AHRQ Publication No. 05-E019-1. Agency for Healthcare Research and Quality, Rockville Ford JG, Howerton MW, Bolen S et al (2005) Knowledge and access to information on recruitment of underrepresented populations to cancer clinical trials. Evidence Report Technology Assessment (Summary) 122:1–11. AHRQ Publication No. 05-E019-1. Agency for Healthcare Research and Quality, Rockville
11.
go back to reference Simon MS, Wei D, Flaherty L et al (2004) Factors associated with breast cancer clinical trials participation and enrollment at a large academic medical center. J Clin Oncol 22:2046–2052CrossRefPubMed Simon MS, Wei D, Flaherty L et al (2004) Factors associated with breast cancer clinical trials participation and enrollment at a large academic medical center. J Clin Oncol 22:2046–2052CrossRefPubMed
12.
go back to reference Ford JG, Howerton MW, Lai GY et al (2008) Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review. Cancer 112:228–242CrossRefPubMed Ford JG, Howerton MW, Lai GY et al (2008) Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review. Cancer 112:228–242CrossRefPubMed
13.
go back to reference David W, Kington R, Madans J et al (2006) Are racial and ethnic minorities less willing to participate in health research? PLoS Med 3:e19, Epub 2005CrossRef David W, Kington R, Madans J et al (2006) Are racial and ethnic minorities less willing to participate in health research? PLoS Med 3:e19, Epub 2005CrossRef
14.
go back to reference Robinson MK, Tsark JAU, Braun KL (2014) Increasing primary care physician support for and promotion of cancer clinical trials. Hawai’i J Med Public Health 73:84–88 Robinson MK, Tsark JAU, Braun KL (2014) Increasing primary care physician support for and promotion of cancer clinical trials. Hawai’i J Med Public Health 73:84–88
16.
go back to reference National Research Council (2005) From cancer patient to cancer survivor: lost in transition. The National Academies Press, Washington, DC National Research Council (2005) From cancer patient to cancer survivor: lost in transition. The National Academies Press, Washington, DC
17.
go back to reference Crosson K, Eisner E, Brown C et al (2001) Primary care physicians’ attitudes, knowledge, and practices related to cancer clinical trials. J Cancer Educ 16:188–192PubMed Crosson K, Eisner E, Brown C et al (2001) Primary care physicians’ attitudes, knowledge, and practices related to cancer clinical trials. J Cancer Educ 16:188–192PubMed
18.
go back to reference Chen DT, Miller FG, Rosenstein DL (2003) Clinical research and the physician-patient relationship. Annnals Intern Med 138:669–672CrossRef Chen DT, Miller FG, Rosenstein DL (2003) Clinical research and the physician-patient relationship. Annnals Intern Med 138:669–672CrossRef
20.
go back to reference Sherwood PR, Given BA, Scholnik A et al (2004) To refer or not to refer: factors that affect primary care provider referral of patients with cancer to clinical treatment trials. J Cancer Educ 19:58–65CrossRefPubMed Sherwood PR, Given BA, Scholnik A et al (2004) To refer or not to refer: factors that affect primary care provider referral of patients with cancer to clinical treatment trials. J Cancer Educ 19:58–65CrossRefPubMed
21.
go back to reference Bernard HR (2005) Research methods in anthropology: qualitative and quantitative approaches, 4th edn. AltaMira Press, Walnut Creek Bernard HR (2005) Research methods in anthropology: qualitative and quantitative approaches, 4th edn. AltaMira Press, Walnut Creek
22.
go back to reference Patton MQ (2002) Qualitative research and evaluation methods, 3rd edn. Sage, Thousand Oaks Patton MQ (2002) Qualitative research and evaluation methods, 3rd edn. Sage, Thousand Oaks
23.
go back to reference Creswell JW (1998) Qualitative inquiry and research design choosing among five traditions. Sage, Thousand Oaks Creswell JW (1998) Qualitative inquiry and research design choosing among five traditions. Sage, Thousand Oaks
24.
go back to reference Miles MB, Huberman AM (1994) Qualitative data analysis: an expanded sourcebook, 2nd ed. Sage, Thousand Oaks Miles MB, Huberman AM (1994) Qualitative data analysis: an expanded sourcebook, 2nd ed. Sage, Thousand Oaks
Metadata
Title
Impact of Primary Care Provider Knowledge, Attitudes, and Beliefs about Cancer Clinical Trials: Implications for Referral, Education and Advocacy
Authors
Margo Michaels
Thomas A. D’Agostino
Natasha Blakeney
Elisa S. Weiss
Maria C. Binz-Scharf
Mitch Golant
Carma L. Bylund
Publication date
01-03-2015
Publisher
Springer US
Published in
Journal of Cancer Education / Issue 1/2015
Print ISSN: 0885-8195
Electronic ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-014-0662-6

Other articles of this Issue 1/2015

Journal of Cancer Education 1/2015 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine